I am/have/had
I am looking for
Advanced Filters
Found 3 clinical trials
Featured trial
Featured trial
Tofacitinib for Immune Skin Conditions in Down Syndrome
People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …
hidradenitis
antimicrobials
eczema
psoriasis
atopy
- 0 views
- 19 Feb, 2024